645 related articles for article (PubMed ID: 10567921)
21. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity.
Khine AA; Tam P; Nutikka A; Lingwood CA
Glycobiology; 2004 Aug; 14(8):701-12. PubMed ID: 15102715
[TBL] [Abstract][Full Text] [Related]
22. STAT1 from the cell membrane to the DNA.
Lillemeier BF; Köster M; Kerr IM
EMBO J; 2001 May; 20(10):2508-17. PubMed ID: 11350940
[TBL] [Abstract][Full Text] [Related]
23. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity.
Chang HM; Paulson M; Holko M; Rice CM; Williams BR; Marié I; Levy DE
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9578-83. PubMed ID: 15210966
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activities of the soluble extracellular domains of type I interferon receptors.
Han CS; Chen Y; Ezashi T; Roberts RM
Proc Natl Acad Sci U S A; 2001 May; 98(11):6138-43. PubMed ID: 11344274
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.
Petricoin EF; Ito S; Williams BL; Audet S; Stancato LF; Gamero A; Clouse K; Grimley P; Weiss A; Beeler J; Finbloom DS; Shores EW; Abraham R; Larner AC
Nature; 1997 Dec; 390(6660):629-32. PubMed ID: 9403695
[TBL] [Abstract][Full Text] [Related]
26. Divergence of binding, signaling, and biological responses to recombinant human hybrid IFN.
Hu R; Bekisz J; Hayes M; Audet S; Beeler J; Petricoin E; Zoon K
J Immunol; 1999 Jul; 163(2):854-60. PubMed ID: 10395679
[TBL] [Abstract][Full Text] [Related]
27. Binding of Escherichia coli verotoxins to cell surface protein on wild-type and globotriaosylceramide-deficient Vero cells.
Devenish J; Gyles C; LaMarre J
Can J Microbiol; 1998 Jan; 44(1):28-34. PubMed ID: 9522446
[TBL] [Abstract][Full Text] [Related]
28. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
29. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon.
Eantuzzi L; Eid P; Malorni W; Rainaldi G; Gauzzi MC; Pellegrini S; Belardelli F; Gessani S
Eur J Immunol; 1997 May; 27(5):1075-81. PubMed ID: 9174595
[TBL] [Abstract][Full Text] [Related]
30. Cytokine-receptor complexes as chaperones for nuclear translocation of signal transducers.
Johnson HM; Torres BA; Green MM; Szente BE; Siler KI; Larkin J; Subramaniam PS
Biochem Biophys Res Commun; 1998 Mar; 244(3):607-14. PubMed ID: 9535713
[TBL] [Abstract][Full Text] [Related]
31. Interferon-alpha induction of STATs1, -3 DNA binding and growth arrest is independent of Lck and active mitogen-activated kinase in T cells.
Lund TC; Medveczky MM; Medveczky PG
Cell Immunol; 1999 Mar; 192(2):133-9. PubMed ID: 10087181
[TBL] [Abstract][Full Text] [Related]
32. Structure-dependent pseudoreceptor intracellular traffic of adamantyl globotriaosyl ceramide mimics.
Saito M; Mylvaganum M; Tam P; Novak A; Binnington B; Lingwood C
J Biol Chem; 2012 May; 287(20):16073-87. PubMed ID: 22418442
[TBL] [Abstract][Full Text] [Related]
33. Identification of functional type I and type II interferon receptors.
Pestka S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1301-19. PubMed ID: 7705745
[TBL] [Abstract][Full Text] [Related]
34. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
35. Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex.
Yokota S; Saito H; Kubota T; Yokosawa N; Amano K; Fujii N
Virology; 2003 Feb; 306(1):135-46. PubMed ID: 12620806
[TBL] [Abstract][Full Text] [Related]
36. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
37. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
[TBL] [Abstract][Full Text] [Related]
39. Localization of the binding site for modified Gb3 on verotoxin 1 using fluorescence analysis.
Picking WD; McCann JA; Nutikka A; Lingwood CA
Biochemistry; 1999 Jun; 38(22):7177-84. PubMed ID: 10353828
[TBL] [Abstract][Full Text] [Related]
40. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
